News

When writing on the web or posting in online communities like Reddit and Discord, your posts can be formatted using the ...
Gilead Sciences' TROP2-targeting drug Trodelvy is already used as a third-line treatment for PD-L1-positive triple-negative breast cancer (TNBC), but could be heading for use in previously ...
Explore the codebase and learn how agent mode is implemented, what context is sent to LLMs, and how we engineer our prompts.' ...
Learn how to solve NYT Strands hint puzzle using LLM. If you're stuck or just want to solve NYT Strands faster, LLMs can help ...
Pentagon Again Shifts Assessment of Damage to Iran’s Nuclear Program The appraisal that Iran’s nuclear hopes had been set back 1 to 2 years by U.S. and Israeli bombings was the latest in a ...
As a first-line therapy, DS-1062/Keytruda had an ORR of 62%, compared to 50% with triple therapy with chemo, with a disease control rate (DCR) or 100% and 90%, respectively.